Deka Biosciences, Inc., is an early-stage biotechnology company focused on generating the next generation targeted cytokine therapies to treat cancer and inflammatory diseases. Deka is developing the dual cytokine, (DiakineTM) platform. Diakines are comprised of optimized, stimulatory, or suppressive disease specific IL-10 variants coupled to other stimulatory or suppressive cytokines via a T1/2 life extending tissue targeting, non-immunogenic scFv technology.
Company Details
- Employees
- 20
- Address
- 20271 Goldenrod Lane,
- Phone
- 6502670338
- mu****@****ces.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- dekabiosciences.com
- HQ
- Germantown, MD
Deka Biosciences, Inc Questions
Deka Biosciences, Inc's helpline number is 6502670338
Deka Biosciences, Inc's website is dekabiosciences.com
Deka Biosciences, Inc's LinkedIn profile is https://www.linkedin.com/company/deka-biosciences-inc
Deka Biosciences, Inc has
20 employees.
View email and phone details for 20
employees at Deka Biosciences, Inc.
Deka Biosciences, Inc's industry is
Biotechnology Research
Deka Biosciences, Inc's top competitors are
Faraday Pharmaceuticals, Inc.,
Indupro,
Arcellx,
Regenxbio,
Mozart Therapeutics, Inc.,
Macrogenics, Inc.,
Oncoc4, Inc.,
Cogentis Therapeutics, Inc.,
Immusoft,
Kaigene, Inc.
Deka Biosciences, Inc's support email address is mummj@dekabiosciences.com
Deka Biosciences, Inc's categories are Biotechnology Research
